The identifier At3g27283 corresponds to a gene locus in Arabidopsis thaliana (a model plant species). Gene nomenclature in this system follows the format:
At: Species abbreviation (A. thaliana)
3g: Chromosome 3
27283: Unique locus identifier
This gene has not been extensively characterized in publicly accessible peer-reviewed studies, and its protein product remains undefined in major databases (e.g., UniProt, TAIR).
Antibodies targeting plant proteins like At3g27283 require:
Antigen Identification: The protein sequence must be confirmed to design immunogens. No structural or functional data for At3g27283 is available in the provided sources or standard repositories.
Validation: Antibodies are typically validated via techniques such as Western blot (WB), immunohistochemistry (IHC), or ELISA. Without a known protein product, validation is impossible.
While no direct data exists for At3g27283, insights can be drawn from analogous studies:
Underexplored Gene: At3g27283 may encode a non-essential or low-abundance protein with no reported functional studies.
Commercial Availability: If an antibody exists, it may be unpublished or restricted to proprietary databases.
Technical Limitations: High sequence similarity to other proteins could hinder specific antibody generation.
Gene Characterization: Perform RNA-seq or proteomic studies to confirm At3g27283 expression.
Collaboration: Partner with antibody core facilities (e.g., Target ALS Reagents Core ) for custom antibody development.
Database Screening: Query specialized repositories like TAIR (The Arabidopsis Information Resource) for updates.
At3g27283 is a gene/protein in Arabidopsis thaliana (Mouse-ear cress), a model organism widely used in plant molecular biology research. While the specific function of At3g27283 is not detailed in current literature, antibodies against this protein enable researchers to detect and quantify it in various experimental contexts. Arabidopsis thaliana is valued in plant biology due to its small genome, rapid life cycle, and ease of genetic manipulation, making it an excellent system for studying fundamental plant processes .
According to the product datasheet, the At3g27283 Antibody has been validated for the following applications:
ELISA (Enzyme-Linked Immunosorbent Assay): For detection and quantification of At3g27283 protein in solution
Western Blotting (WB): For detection of At3g27283 protein after separation by gel electrophoresis
When designing experiments, researchers should ensure their methodology aligns with these validated applications. The antibody has been specifically tested to ensure identification of the target antigen .
The At3g27283 Antibody should be stored at -20°C or -80°C upon receipt. It is critical to avoid repeated freeze-thaw cycles as these can degrade antibody quality. The antibody is supplied in liquid form with the following storage buffer:
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
For long-term stability, aliquot the antibody into smaller volumes before freezing to minimize freeze-thaw cycles when only portions are needed for experiments .
Validating antibody specificity is crucial for reliable research results. For At3g27283 Antibody, implement the following approaches:
Genetic Controls:
Use knockout/knockdown lines of At3g27283 in Arabidopsis thaliana
Compare wild-type plants with transgenic plants overexpressing At3g27283
Molecular Weight Verification:
Confirm the detected band matches the predicted molecular weight of At3g27283
Account for potential shifts due to post-translational modifications
Peptide Competition Assay:
Pre-incubate the antibody with excess purified At3g27283 protein or immunizing peptide
A specific antibody should show significantly reduced signal
Orthogonal Detection Methods:
Correlate protein detection with mRNA levels using RT-PCR or RNA-seq
Use mass spectrometry to confirm the identity of immunoprecipitated protein
A comprehensive validation strategy employs multiple approaches to build confidence in antibody specificity before proceeding with complex experiments. Since this is a polyclonal antibody raised against recombinant Arabidopsis thaliana At3g27283 protein, it may recognize multiple epitopes .
When working with potentially low-abundance targets like At3g27283 in plant tissues, consider these optimization strategies:
Sample Preparation:
Grind tissues in liquid nitrogen to preserve protein integrity
Use optimized extraction buffers with appropriate protease inhibitors
Consider subcellular fractionation to concentrate target protein
Western Blot Enhancement:
Increase protein load (30-50 μg per lane)
Extend primary antibody incubation (overnight at 4°C)
Use high-sensitivity detection systems (chemiluminescence)
ELISA Optimization:
Evaluate different coating buffers (carbonate/bicarbonate at pH 9.6)
Titrate antibody concentrations to determine optimal signal-to-noise ratio
Extend incubation times while maintaining low background
Since this antibody is affinity-purified, it may provide better specificity for detecting low-abundance targets compared to crude antiserum preparations .
Integrating At3g27283 Antibody into advanced proteomic workflows requires careful consideration of several technical aspects:
Immunoprecipitation for Protein-Protein Interaction Studies:
Optimize antibody-to-bead coupling ratios (typically 5-10 μg antibody per 50 μL of protein A/G beads)
Determine optimal extraction conditions that preserve protein complexes
Implement appropriate controls (IgG control, input sample)
Mass Spectrometry Integration:
Ensure antibody purification method doesn't introduce contaminants
Use appropriate elution methods compatible with downstream MS
Implement appropriate normalization and quantification strategies
Data Analysis Considerations:
Implement appropriate normalization methods
Account for technical variation through replicates
Validate findings with independent methodologies
Similar integration approaches have been successful with antibodies targeting other plant proteins, as demonstrated in studies using computational methods like H3-OPT for analyzing antibody structures and their applications .
Based on standard practices for polyclonal antibodies like At3g27283 Antibody, the following protocol is recommended:
Extract total protein from Arabidopsis thaliana tissues using an appropriate buffer (e.g., RIPA buffer with protease inhibitors)
Determine protein concentration using Bradford or BCA assay
Prepare samples containing 20-30 μg total protein mixed with Laemmli buffer
Heat samples at 95°C for 5 minutes
Load samples onto an SDS-PAGE gel (10-12% acrylamide)
Include molecular weight markers
Run gel at 100-120V until adequate separation is achieved
Transfer proteins to PVDF or nitrocellulose membrane
Block membrane with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature
Incubate with primary At3g27283 Antibody at 1:1000 dilution in blocking buffer overnight at 4°C
Wash 3 times with TBST, 5-10 minutes each
Incubate with HRP-conjugated secondary anti-rabbit antibody at 1:5000 dilution for 1 hour
Wash 3 times with TBST, 5-10 minutes each
Detect signal using ECL substrate and imaging system
Quantify band intensity using appropriate software
Normalize to loading control (e.g., GAPDH, actin, or total protein stain)
When encountering weak or absent signals, implement this systematic troubleshooting approach:
Insufficient Target Protein:
Increase total protein loaded (up to 50-60 μg)
Use protein concentration methods (e.g., TCA precipitation)
Consider subcellular fractionation if the protein is compartmentalized
Antibody-Related Issues:
Titrate antibody concentration (try 1:500 to 1:2000 dilutions)
Extend primary antibody incubation (up to 48 hours at 4°C)
Check antibody storage conditions and expiration
Assess if multiple freeze-thaw cycles have affected antibody performance
Technical Issues:
Verify transfer efficiency using reversible protein stains
Optimize blocking conditions (type, concentration, duration)
Test different membrane types (PVDF vs. nitrocellulose)
Enhance detection system (use high-sensitivity ECL substrates)
Create a troubleshooting matrix where you change one variable at a time while maintaining all others constant. Document results carefully to identify the critical parameters affecting detection .
For quantitative experiments using At3g27283 Antibody, implement these rigorous methods:
Experimental Design:
Include biological replicates (n ≥ 3)
Plan technical replicates within each biological sample
Include appropriate positive and negative controls
Design experiments to test the linear range of detection
Western Blot Quantification:
Use a digital imaging system with a linear dynamic range
Avoid film exposure for quantification (limited dynamic range)
Capture multiple exposure times to ensure signals are within linear range
Normalization Strategies:
For Western blots: normalize to housekeeping proteins or total protein stains
For ELISA: use standard curves with appropriate curve fitting (4PL model recommended)
Statistical Analysis:
Perform appropriate statistical tests based on experimental design
Use ANOVA with post-hoc tests for multiple comparisons
Report effect sizes along with p-values
| Treatment Group | Relative At3g27283 Expression (Mean ± SEM) | Fold Change vs. Control | Statistical Significance |
|---|---|---|---|
| Control | 1.00 ± 0.12 | - | - |
| Treatment A | 2.47 ± 0.31 | 2.47 | p < 0.01 |
| Treatment B | 0.43 ± 0.09 | 0.43 | p < 0.05 |
| Treatment C | 1.12 ± 0.18 | 1.12 | ns |
This sample data table format demonstrates proper reporting of quantitative Western blot results .
When designing experiments to study At3g27283 expression across developmental stages:
Sampling Strategy:
Collect tissues at defined developmental stages (seedling, vegetative, reproductive)
Sample specific organs (roots, stems, leaves, flowers, siliques) at each stage
Maintain consistent harvesting times to control for circadian effects
Experimental Controls:
Include tissue-specific positive controls (proteins known to be expressed in each tissue)
Use genetically modified lines (overexpression, knockdown) as reference points
Consider environmentally matched wild-type controls
Quantification Approach:
Implement absolute quantification using recombinant protein standards
Track relative changes normalized to stable reference proteins
Correlate protein levels with transcript abundance through RT-qPCR
Validation Methods:
Confirm expression patterns with immunolocalization techniques
Verify antibody specificity with negative controls for each tissue type
Complement protein data with promoter-reporter studies
Similar experimental designs have been used effectively in studies characterizing other Arabidopsis proteins and could be adapted for At3g27283 .
When designing co-immunoprecipitation (Co-IP) experiments with At3g27283 Antibody:
Extraction Conditions:
Use gentle lysis buffers (avoid strong detergents that may disrupt protein-protein interactions)
Optimize salt concentration (typically 100-150 mM NaCl)
Include protease and phosphatase inhibitors to preserve native interactions
Perform extractions at 4°C to minimize protein degradation
IP Protocol Optimization:
Test different antibody amounts (typically 2-5 μg per mg of total protein)
Compare direct antibody coupling to beads versus indirect capture
Determine optimal incubation times (4-16 hours at 4°C with gentle rotation)
Optimize wash stringency to remove non-specific binders
Controls:
Include IP with non-specific IgG from the same species
Use lysate from knockout/knockdown plants as negative controls
Consider reverse Co-IP to confirm interactions
Include input samples (typically 5-10% of starting material)
Detection Methods:
Western blot with antibodies against suspected interaction partners
Mass spectrometry for unbiased identification of co-precipitated proteins
Correlate with yeast two-hybrid or other in vitro interaction data
These methodological considerations are similar to those used in advanced antibody research applications as described in H3-OPT antibody structure studies .
When facing discrepancies between protein levels detected by At3g27283 Antibody and gene expression data:
Biological Explanations:
Post-transcriptional regulation may cause protein and mRNA levels to differ
Protein stability and turnover rates affect steady-state protein levels
Translational efficiency might vary under different conditions
Post-translational modifications could affect antibody recognition
Technical Considerations:
Verify antibody specificity under your experimental conditions
Assess whether the antibody recognizes all isoforms or specific variants
Check if experimental conditions affect epitope accessibility
Ensure RNA and protein samples represent the same biological state
Analytical Approach:
Calculate protein-to-mRNA ratios across conditions to identify regulatory patterns
Implement time-course studies to detect temporal delays between transcription and translation
Use pharmacological inhibitors of protein synthesis or degradation to assess protein turnover
Consider pulse-chase experiments to measure protein half-life
Validation Strategy:
Test multiple primer sets and antibodies targeting different epitopes
Implement orthogonal techniques (e.g., mass spectrometry)
Use reporter constructs to monitor transcription and translation independently
This approach to resolving data conflicts is consistent with best practices in antibody-based research and structural prediction methods for antibodies .
When analyzing data from experiments using At3g27283 Antibody:
Descriptive Statistics:
Calculate means, standard deviations, and standard errors
Assess data distribution (normality tests like Shapiro-Wilk)
Generate box plots or violin plots to visualize data distribution
Inferential Statistics:
For comparing two groups: t-test (parametric) or Mann-Whitney U test (non-parametric)
For multiple groups: ANOVA with appropriate post-hoc tests (Tukey, Bonferroni)
For non-normal data: Kruskal-Wallis with Dunn's post-hoc test
Correlation Analysis:
Pearson correlation (parametric) or Spearman rank correlation (non-parametric)
Regression analysis for predictive relationships
Path analysis for complex relationship networks
Advanced Methods:
Mixed-effects models for nested experimental designs
Multiple comparison correction methods (FDR, Bonferroni)
Power analysis for determining adequate sample size
Reporting Requirements:
Include exact p-values rather than threshold indicators
Report effect sizes alongside significance values
Clearly state biological and technical replication numbers
Specify software and versions used for analysis
These statistical approaches align with best practices described in data table guidelines for biological research .